妊娠合并淋巴瘤的研究进展

目前癌症已成为育龄女性第二大死因,妊娠合并淋巴瘤的发病率位于妊娠女性合并癌症的第4位,发病率约为1∶6000,其诊断与治疗涉及母亲与胎儿双方的利益权衡。随着治疗技术的进步,肿瘤的存活者日益增多。但有效的治疗往往导致不孕。育龄期未生育的女性罹患肿瘤,将面临更多生殖需求的挑战。如何优化母儿双方的预后,是有效干预妊娠合并淋巴瘤的关键。该文就妊娠合并淋巴瘤的研究进展予以综述。

Research Progress of Lymphoma during Pregnancy

Cancer is the second most common cause of death in women of reproductive age.Lymphoma is the fourth most common malignancy in pregnancy,with an estimated prevalence of 1 in 6000 pregnancies.The diagnosis and treatment involves the balance between optimal maternal therapy and fetal well-being.As cancer therapy is becoming more efficacious,there are more survivors.Lnfortunately,many of the successful treatment options for cancer lead to infertility.Women of reproductive age,who have not given birth,will face more challenges in reproductive health.The key to intervene this disease is to optimize the mother＇s chances for cure and the safety of the fetus.llere is to make a review of the progress in research of lymphoma during pregnancy.